Status:

UNKNOWN

Mu Opioid Receptor 1 Expression and Activation Patterns in Colorectal Cancer

Lead Sponsor:

Hospital Universitario La Fe

Conditions:

Colorectal Surgery for Stage II / III Primary Colorectal Cancer

Eligibility:

All Genders

18+ years

Brief Summary

Observational case-control study in a retrospective cohort of patients with stage II or III colorectal cancer undergoing scheduled surgery.

Detailed Description

Observational case-control study in a retrospective cohort of patients with stage II or III colorectal cancer undergoing scheduled surgery. Period January 2010-December 2014. Patients must have had at...

Eligibility Criteria

Inclusion

  • Patients over 18 years of age.
  • Colorectal surgery scheduled between January 2010 - December 2014.
  • Stage II or III colon or rectum neoplasm (T3 / T4 N + M0).

Exclusion

  • Neoplasia of colon or rectum in Stage I or Stage IV.
  • Non-oncological colorectal surgery.
  • Urgent surgery

Key Trial Info

Start Date :

June 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2022

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04353882

Start Date

June 1 2020

End Date

June 1 2022

Last Update

May 19 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Mu Opioid Receptor 1 Expression and Activation Patterns in Colorectal Cancer | DecenTrialz